BEYOND MEAT, INC.

Note 5. Property, Plant and Equipment

The Company records property, plant, and equipment at cost and includes finance lease assets in Property, plant and equipment, net in its unaudited condensed consolidated balance sheets. A summary of property, plant, and equipment as of September 27, 2025 and December 31, 2024, is as follows:

Depreciation and amortization expense in the three months ended September 27, 2025 and September 28, 2024 was $9.4 million and $5.3 million, respectively. Depreciation and amortization expense in the three months ended September 27, 2025 included $1.7 million in accelerated depreciation related to the reassessment of useful lives of certain assets resulting from the suspension and substantial cessation of the Company’s operational activities in China. Of the total depreciation and amortization expense in the three months ended September 27, 2025 and September 28, 2024, $6.1 million (including $1.7 million in accelerated depreciation related to the reassessment of useful lives of certain assets resulting from the suspension and substantial cessation of the Company’s operational activities in China) and $4.7 million, respectively, were recorded in cost of goods sold, $2.6 million and $0.5 million, respectively, were recorded in research and development expenses, and $0.7 million and $0.1 million, respectively, were recorded in SG&A expenses, in the Company’s unaudited condensed consolidated statements of operations.

Depreciation and amortization expense in the nine months ended September 27, 2025 and September 28, 2024 was $25.0 million and $17.5 million, respectively. Depreciation and amortization expense in the nine months ended September 27, 2025 included $4.9 million in accelerated depreciation related to the reassessment of useful lives of certain assets resulting from the suspension and substantial cessation of the Company’s operational activities in China. Of the total depreciation and amortization expense in the nine months ended September 27, 2025 and September 28, 2024, $18.1 million (including $4.0 million in accelerated depreciation related to the reassessment of useful lives of certain assets resulting from the suspension and substantial cessation of the Company’s operational activities in China) and $15.3 million, respectively, were recorded in cost of goods sold, $6.0 million (including $0.9 million in accelerated depreciation related to the reassessment of useful lives of certain assets resulting from the suspension and substantial cessation of the Company’s operational activities in China), and $1.5 million, respectively, were recorded in research and development expenses, and $0.9 million and $0.7 million, respectively, were recorded in SG&A expenses, in the Company’s unaudited condensed consolidated statements of operations.

The Company had $0.9 million and $1.9 million in property, plant and equipment concluded to meet the criteria for assets held for sale as of September 27, 2025 and December 31, 2024, respectively. The Company recorded $0.1 million in gain on sale of fixed assets and $(0.1) million in loss on sale of fixed assets in the three months ended September 27, 2025 and September 28, 2024, respectively, and $(0.1) million and $(0.5) million in loss on sale of fixed assets in the nine months ended September 27, 2025 and September 28, 2024, respectively.

In the three and nine months ended September 27, 2025, the Company recorded an impairment charge related to property, plant and equipment in the amount of $58.8 million. See Note 6.